American Pancreatic Association, December 2023 – Poster presentation “SAFE-D Trial design: Targeted pancreatic cancer screening to evaluate stage and resectability rate shift in patients with new-onset diabetes.”
Meet Us At ADA Booth #1814 ClearNote Health is a cancer detection company focused on enabling people at risk for high-mortality cancers to live longer, healthier lives. Our first product, the Avantect Pancreatic Cancer Test, is a test for patients at high risk for...
American Diabetes Association 83rd Scientific Sessions, June 2023 – Poster presentation entitled “Implementation of the Avantect Pancreatic Cancer Test in Newly Diagnosed Type 2 Diabetes Patients in a Clinical Setting.” Meet Us At ADA Booth #1814 ClearNote...
